1. Market Research
  2. > Healthcare Market Trends
  3. > Denmark Pharmaceuticals and Healthcare Report Q1 2017

Denmark Pharmaceuticals and Healthcare Report Q1 2017

  • November 2016
  • -
  • Business Monitor International
  • -
  • 50 pages

Includes 3 FREE quarterly updates


BMI View:

Growth in Denmark’s relatively small pharmaceutical sector will remain sluggish in the coming years, a result of weak external demand and overall economic performance. However, over the longer term, we expect growth to gradually improve, driven by the rising demand for high-value medicines needed by an ageing population. Furthermore, Denmark’s strong intellectual property protection, well-funded healthcare system and well-developed research environment make the country a highly attractive market for innovative drugmakers.

Headline Expenditure Projections



- Pharmaceuticals: DKK21.50bn (USD3.20bn) in 2015 to DKK21.68bn (USD3.11bn) in 2016; +0.8% in local currency terms and -2.7% in US dollar terms. Forecast remains in line with last quarter.

- Healthcare: DKK204.36bn (USD30.42bn) in 2015 to DKK207.74bn (USD29.83bn) in 2016; +1.7% in local currency terms and -1.9% in US dollar terms. Forecast revised downwards from last quarter. Risk/Reward Index Denmark scores 72.8 out of a total of 100 in our Q117 Risk Reward Index, unchanged from last quarter. The country moves up from seventh position to fifth in our Western Europe matrix, sitting between the UK (with a score of 72.9) and Finland (72.2). Denmark’s strong emphasis on the regulatory environment is a draw, although a major factor affecting the business environment for drugmakers is the country’s small overall market size (market expenditure score of 12.0 out of 20). Combined with pressure on pharmaceutical spending, this negatively affects the Industry Rewards score in particular. Nevertheless, given its high per capita drug expenditure (its spending per capita score comes to 9.6 out of 12), medicines bring in substantial income for companies operating in the country.

Table Of Contents

Denmark Pharmaceuticals and Healthcare Report Q1 2017
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Denmark 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Denmark 2012-2020) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Denmark 2012-2020) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Denmark 2012-2020) 17
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Denmark 2012-2020) 17
Industry Risk/Reward Index 18
Western Europe Risk/Reward Index 18
Denmark Risk/Reward Index 23
Rewards 23
Risks 24
Regulatory Review 25
Pricing Regime 26
Reimbursement Regime 27
Market Overview 29
Healthcare Sector 30
Table: Healthcare Resources (Denmark 2010-2015) 30
Table: Healthcare Personnel (Denmark 2010-2015) 30
Table: Healthcare Activity (Denmark 2010-2015) 31
Research and Development 31
Clinical Trials 31
Epidemiology 33
Competitive Landscape 35
Research-Based Industry 35
Table: LIF Member Companies 36
Table: Multinational Market Activity 37
Generic Drugmakers 38
Pharmaceutical Retail Sector 38
Demographic Forecast 39
Denmark Demographic Forecast 39
Table: Population Headline Indicators (Denmark 1990-2025) 40
Table: Key Population Ratios (Denmark 1990-2025) 40
Table: Urban/Rural Population and Life Expectancy (Denmark 1990-2025) 41
Table: Population By Age Group (Denmark 1990-2025) 41
Table: Population By Age Group % (Denmark 1990-2025) 42
Glossary 44
Methodology 46
Pharmaceutical Expenditure Forecast Model 46
Healthcare Expenditure Forecast Model 46
Notes On Methodology 47
Risk/Reward Index Methodology 48
Index Overview 49
Table: Pharmaceutical Risk/Reward Index Indicators 49
Indicator Weightings 50

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Germany Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monitor

Germany Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monitor

  • $ 5995
  • Industry report
  • November 2016
  • by Global Data

Germany Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-El ...

Australia Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monit

Australia Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monit

  • $ 5995
  • Industry report
  • November 2016
  • by Global Data

Australia Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro- ...

India Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monitorin

India Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monitorin

  • $ 5995
  • Industry report
  • November 2016
  • by Global Data

India Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical ...


Download Unlimited Documents from Trusted Public Sources

Public Health Industry in the UK - Forecast

  • December 2016
    60 pages
  • Public Health  

  • United Kingdom  

    Europe  

View report >

Public Health Industry in the UK

  • December 2016
    156 pages
  • Public Health  

    Neurological Di...  

    Hospital  

  • United Kingdom  

View report >

Public Health Markets in the UK

  • December 2016
    45 pages
  • Public Health  

    Obesity  

    Food  

  • United Kingdom  

    Europe  

View report >

Related Market Segments :

Healthcare
Pharmaceutical

ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.